Mendota Financial Group’s Labcorp LH Stock Holding History

Mendota Financial Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-129	Closed	-$29.3K	–	363
2023 Q4	$29.3K	Buy	+129	New	+$27.1K	0.02%	227

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mendota Financial Group's LH Position: Q1 2024 in Review

Mendota Financial Group sold out of Labcorp (LH) in Q1 2024, closing a stake of 129 shares — an estimated $29.3K sold.

Mendota Financial Group first reported a position in LH in Q4 2023 and held it in 1 quarter. The position peaked at $29.3K in Q4 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

Mendota Financial Group reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
Mendota Financial Group sold 129 Labcorp shares in Q1 2024, an estimated $29.3K.
Mendota Financial Group first reported a position in Labcorp in Q4 2023 and held it in 1 quarter.
Mendota Financial Group's Labcorp position peaked at $29.3K in Q4 2023.
927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Mendota Financial Group's 13F filing for Q1 2024, filed 25 Apr 2024.